These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12163391)

  • 1. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.
    Watson MA; Gutmann DH; Peterson K; Chicoine MR; Kleinschmidt-DeMasters BK; Brown HG; Perry A
    Am J Pathol; 2002 Aug; 161(2):665-72. PubMed ID: 12163391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
    Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
    Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
    Schulten HJ; Hussein D
    PLoS One; 2019; 14(5):e0215452. PubMed ID: 31083655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip.
    Sasaki T; Hankins GR; Helm GA
    Neurosurgery; 2003 Apr; 52(4):892-8; discussion 898-9. PubMed ID: 12657186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
    Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
    Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
    Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
    Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status.
    Goutagny S; Yang HW; Zucman-Rossi J; Chan J; Dreyfuss JM; Park PJ; Black PM; Giovannini M; Carroll RS; Kalamarides M
    Clin Cancer Res; 2010 Aug; 16(16):4155-64. PubMed ID: 20682713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningioma transcript profiles reveal deregulated Notch signaling pathway.
    Cuevas IC; Slocum AL; Jun P; Costello JF; Bollen AW; Riggins GJ; McDermott MW; Lal A
    Cancer Res; 2005 Jun; 65(12):5070-5. PubMed ID: 15958550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of genes differentially expressed in meningiomas.
    Murphy M; Pykett MJ; Harnish P; Zang KD; George DL
    Cell Growth Differ; 1993 Sep; 4(9):715-22. PubMed ID: 7694637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.
    Pérez-Magán E; Rodríguez de Lope A; Ribalta T; Ruano Y; Campos-Martín Y; Pérez-Bautista G; García JF; García-Claver A; Fiaño C; Hernández-Moneo JL; Mollejo M; Meléndez B
    Neuro Oncol; 2010 Dec; 12(12):1278-90. PubMed ID: 20685720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression?
    Fukami S; Riemenschneider MJ; Kohno M; Steiger HJ
    Brain Tumor Pathol; 2016 Jul; 33(3):191-9. PubMed ID: 26942600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.
    Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF
    Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological analysis of receptor tyrosine kinases in meningiomas: the expression of VEGFR-2 in meningioma was associated with a higher WHO grade and shorter progression-free survival.
    Nakada S; Sasagawa Y; Tachibana O; Iizuka H; Kurose N; Shioya A; Guo X; Yamada S; Nojima T
    Brain Tumor Pathol; 2019 Jan; 36(1):7-13. PubMed ID: 30519894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.
    Nordqvist AC; Mathiesen T
    J Neurooncol; 2002 Mar; 57(1):19-26. PubMed ID: 12125963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High thioredoxin reductase 1 expression in meningiomas undergoing malignant progression.
    Esen H; Feyzioglu B; Erdi F; Keskin F; Kaya B; Demir LS
    Brain Tumor Pathol; 2015 Jul; 32(3):195-201. PubMed ID: 25592259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression.
    Schulten HJ; Hussein D; Al-Adwani F; Karim S; Al-Maghrabi J; Al-Sharif M; Jamal A; Al-Ghamdi F; Baeesa SS; Bangash M; Chaudhary A; Al-Qahtani M
    PLoS One; 2016; 11(4):e0153681. PubMed ID: 27096627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation in the malignant transformation of meningiomas.
    Gao F; Shi L; Russin J; Zeng L; Chang X; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Mack WJ; Wang K
    PLoS One; 2013; 8(1):e54114. PubMed ID: 23349797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular biology of hormone and growth factor receptors in meningiomas.
    Black P; Carroll R; Zhang J
    Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations associated with progression and recurrence in meningiomas.
    Pérez-Magán E; Campos-Martín Y; Mur P; Fiaño C; Ribalta T; García JF; Rey JA; Rodríguez de Lope A; Mollejo M; Meléndez B
    J Neuropathol Exp Neurol; 2012 Oct; 71(10):882-93. PubMed ID: 22964784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.